Concepedia

Publication | Closed Access

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

DOI

2.4K

Citations

26

References

2009

Year

Henry S. Friedman, Michael D. Prados, Patrick Y. Wen, Tom Mikkelsen, David Schiff, Lauren E. Abrey, W.K. Alfred Yung, Nina A. Paleologos, M. Kelly Nicholas, Randy L. Jensen,
Journal of Clinical Oncology

Abstract

Bevacizumab, alone or in combination with irinotecan, was well tolerated and active in recurrent glioblastoma.

References

YearCitations

Page 1